Litcius/Paper detail

Tumor Necrosis Factor: What Is in a Name?

Xinming Wang, Chunlan Yang, Heinrich Körner, Chaoliang Ge

2022Cancers14 citationsDOIOpen Access PDF

Abstract

Tumor Necrosis Factor was one of the first cytokines described in the literature as a soluble mediator of cytotoxicity to tumors. Over the years, more extensive research that tried to employ Tumor Necrosis Factor in cancer treatments showed nevertheless that it mainly functioned as a proinflammatory cytokine. However, this did not stop the search for the holy grail of cancer research: A cytokine that could act as a one-stop treatment for solid tumors and lymphomas. This review will summarize the long experimental history of Tumor Necrosis Factor that caused the initial observations of a tumor necrotizing cytokine that could serve as a potential cancer treatment and discuss the current state of research into this side of the activities of Tumor Necrosis Factor.

Topics & Concepts

Tumor necrosis factor alphaProinflammatory cytokineCytokineHoly GrailNecrosisMedicineTumor necrosis factorsCD30CancerMediatorCancer researchImmunologyPathologyTumor cellsInternal medicineInflammationComputer scienceWorld Wide WebImmune Response and InflammationCell death mechanisms and regulationImmunotherapy and Immune Responses
Tumor Necrosis Factor: What Is in a Name? | Litcius